Financhill
Sell
49

MORN Quote, Financials, Valuation and Earnings

Last price:
$340.59
Seasonality move :
2.11%
Day range:
$336.12 - $341.50
52-week range:
$269.51 - $365.00
Dividend yield:
0.48%
P/E ratio:
44.96x
P/S ratio:
6.60x
P/B ratio:
9.32x
Volume:
269.5K
Avg. volume:
165.4K
1-year change:
22.08%
Market cap:
$14.6B
Revenue:
$2B
EPS (TTM):
$7.57

Price Performance History

Performance vs. Valuation Benchmarks

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Competitors

Company Revenue Forecast Earnings Forecast Revenue Growth Forecast Earnings Growth Forecast Analyst Price Target Median
MORN
Morningstar
$565.7M $2.00 7.04% 18.74% --
CME
CME Group
$1.6B $2.65 6.06% 10.53% $242.38
FDS
FactSet Research Systems
$565M $4.28 4.43% 15.63% $471.11
MSCI
MSCI
$717.7M $3.77 8.19% -22.05% $656.64
NDAQ
Nasdaq
$1.2B $0.69 -26.21% 104.92% $84.17
VALU
Value Line
-- -- -- -- --
Company Price Analyst Target Market Cap P/E Ratio Dividend per Share Dividend Yield Price / LTM Sales
MORN
Morningstar
$340.36 -- $14.6B 44.96x $0.41 0.48% 6.60x
CME
CME Group
$238.53 $242.38 $86B 25.08x $1.15 4.13% 14.20x
FDS
FactSet Research Systems
$483.52 $471.11 $18.4B 34.66x $1.04 0.85% 8.37x
MSCI
MSCI
$604.80 $656.64 $47.4B 39.71x $1.60 1.06% 17.10x
NDAQ
Nasdaq
$77.70 $84.17 $44.7B 46.53x $0.24 1.21% 6.34x
VALU
Value Line
$54.14 -- $509.9M 23.04x $0.30 2.18% 14.23x
Company Total Debt / Total Capital Beta Debt to Equity Quick Ratio
MORN
Morningstar
35.58% 1.064 6.32% 1.04x
CME
CME Group
10.83% 0.424 4.32% 0.03x
FDS
FactSet Research Systems
40.56% 0.880 7.5% 1.14x
MSCI
MSCI
120.11% 1.513 9.82% 0.83x
NDAQ
Nasdaq
47.1% 0.730 23.49% 0.18x
VALU
Value Line
-- 1.178 0.62% 3.38x
Company Gross Profit Operating Income Return on Invested Capital Return on Common Equity EBIT Margin Free Cash Flow
MORN
Morningstar
$346.7M $115.5M 13.96% 23.47% 28.8% $155.8M
CME
CME Group
$1.4B $1B 11.18% 12.57% 76.82% $973.2M
FDS
FactSet Research Systems
$309.9M $191.3M 16.33% 28.97% 34.14% $60.5M
MSCI
MSCI
$598.5M $401.3M 32.46% -- 55.7% $394M
NDAQ
Nasdaq
$734M $480M 4.8% 9.57% 23.87% $188M
VALU
Value Line
$5.3M $1.7M 24.37% 24.37% 19.73% $3M

Morningstar vs. Competitors

  • Which has Higher Returns MORN or CME?

    CME Group has a net margin of 21.02% compared to Morningstar's net margin of 57.61%. Morningstar's return on equity of 23.47% beat CME Group's return on equity of 12.57%.

    Company Gross Margin Earnings Per Share Invested Capital
    MORN
    Morningstar
    60.89% $2.77 $2.4B
    CME
    CME Group
    86.19% $2.50 $31.6B
  • What do Analysts Say About MORN or CME?

    Morningstar has a consensus price target of --, signalling upside risk potential of 10.18%. On the other hand CME Group has an analysts' consensus of $242.38 which suggests that it could grow by 1.61%. Given that Morningstar has higher upside potential than CME Group, analysts believe Morningstar is more attractive than CME Group.

    Company Buy Ratings Hold Ratings Sell Ratings
    MORN
    Morningstar
    0 0 0
    CME
    CME Group
    5 8 0
  • Is MORN or CME More Risky?

    Morningstar has a beta of 1.193, which suggesting that the stock is 19.256% more volatile than S&P 500. In comparison CME Group has a beta of 0.563, suggesting its less volatile than the S&P 500 by 43.731%.

  • Which is a Better Dividend Stock MORN or CME?

    Morningstar has a quarterly dividend of $0.41 per share corresponding to a yield of 0.48%. CME Group offers a yield of 4.13% to investors and pays a quarterly dividend of $1.15 per share. Morningstar pays 45.29% of its earnings as a dividend. CME Group pays out 100.29% of its earnings as a dividend. Morningstar's payout ratio is sufficient to cover dividend payouts with earnings for the foreseeable future, but CME Group's is not.

  • Which has Better Financial Ratios MORN or CME?

    Morningstar quarterly revenues are $569.4M, which are smaller than CME Group quarterly revenues of $1.6B. Morningstar's net income of $119.7M is lower than CME Group's net income of $912.8M. Notably, Morningstar's price-to-earnings ratio is 44.96x while CME Group's PE ratio is 25.08x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Morningstar is 6.60x versus 14.20x for CME Group. Usually stocks with elevated PS ratios are considered overvalued.

    Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income
    MORN
    Morningstar
    6.60x 44.96x $569.4M $119.7M
    CME
    CME Group
    14.20x 25.08x $1.6B $912.8M
  • Which has Higher Returns MORN or FDS?

    FactSet Research Systems has a net margin of 21.02% compared to Morningstar's net margin of 26.38%. Morningstar's return on equity of 23.47% beat FactSet Research Systems's return on equity of 28.97%.

    Company Gross Margin Earnings Per Share Invested Capital
    MORN
    Morningstar
    60.89% $2.77 $2.4B
    FDS
    FactSet Research Systems
    54.49% $3.89 $3.4B
  • What do Analysts Say About MORN or FDS?

    Morningstar has a consensus price target of --, signalling upside risk potential of 10.18%. On the other hand FactSet Research Systems has an analysts' consensus of $471.11 which suggests that it could fall by -2.57%. Given that Morningstar has higher upside potential than FactSet Research Systems, analysts believe Morningstar is more attractive than FactSet Research Systems.

    Company Buy Ratings Hold Ratings Sell Ratings
    MORN
    Morningstar
    0 0 0
    FDS
    FactSet Research Systems
    2 11 3
  • Is MORN or FDS More Risky?

    Morningstar has a beta of 1.193, which suggesting that the stock is 19.256% more volatile than S&P 500. In comparison FactSet Research Systems has a beta of 0.763, suggesting its less volatile than the S&P 500 by 23.653%.

  • Which is a Better Dividend Stock MORN or FDS?

    Morningstar has a quarterly dividend of $0.41 per share corresponding to a yield of 0.48%. FactSet Research Systems offers a yield of 0.85% to investors and pays a quarterly dividend of $1.04 per share. Morningstar pays 45.29% of its earnings as a dividend. FactSet Research Systems pays out 28.05% of its earnings as a dividend. Both of these payout ratios are sufficient to cover dividend payouts with earnings for the foreseeable future.

  • Which has Better Financial Ratios MORN or FDS?

    Morningstar quarterly revenues are $569.4M, which are larger than FactSet Research Systems quarterly revenues of $568.7M. Morningstar's net income of $119.7M is lower than FactSet Research Systems's net income of $150M. Notably, Morningstar's price-to-earnings ratio is 44.96x while FactSet Research Systems's PE ratio is 34.66x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Morningstar is 6.60x versus 8.37x for FactSet Research Systems. Usually stocks with elevated PS ratios are considered overvalued.

    Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income
    MORN
    Morningstar
    6.60x 44.96x $569.4M $119.7M
    FDS
    FactSet Research Systems
    8.37x 34.66x $568.7M $150M
  • Which has Higher Returns MORN or MSCI?

    MSCI has a net margin of 21.02% compared to Morningstar's net margin of 38.76%. Morningstar's return on equity of 23.47% beat MSCI's return on equity of --.

    Company Gross Margin Earnings Per Share Invested Capital
    MORN
    Morningstar
    60.89% $2.77 $2.4B
    MSCI
    MSCI
    82.59% $3.57 $3.7B
  • What do Analysts Say About MORN or MSCI?

    Morningstar has a consensus price target of --, signalling upside risk potential of 10.18%. On the other hand MSCI has an analysts' consensus of $656.64 which suggests that it could grow by 8.57%. Given that Morningstar has higher upside potential than MSCI, analysts believe Morningstar is more attractive than MSCI.

    Company Buy Ratings Hold Ratings Sell Ratings
    MORN
    Morningstar
    0 0 0
    MSCI
    MSCI
    7 4 0
  • Is MORN or MSCI More Risky?

    Morningstar has a beta of 1.193, which suggesting that the stock is 19.256% more volatile than S&P 500. In comparison MSCI has a beta of 1.103, suggesting its more volatile than the S&P 500 by 10.277%.

  • Which is a Better Dividend Stock MORN or MSCI?

    Morningstar has a quarterly dividend of $0.41 per share corresponding to a yield of 0.48%. MSCI offers a yield of 1.06% to investors and pays a quarterly dividend of $1.60 per share. Morningstar pays 45.29% of its earnings as a dividend. MSCI pays out 38.39% of its earnings as a dividend. Both of these payout ratios are sufficient to cover dividend payouts with earnings for the foreseeable future.

  • Which has Better Financial Ratios MORN or MSCI?

    Morningstar quarterly revenues are $569.4M, which are smaller than MSCI quarterly revenues of $724.7M. Morningstar's net income of $119.7M is lower than MSCI's net income of $280.9M. Notably, Morningstar's price-to-earnings ratio is 44.96x while MSCI's PE ratio is 39.71x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Morningstar is 6.60x versus 17.10x for MSCI. Usually stocks with elevated PS ratios are considered overvalued.

    Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income
    MORN
    Morningstar
    6.60x 44.96x $569.4M $119.7M
    MSCI
    MSCI
    17.10x 39.71x $724.7M $280.9M
  • Which has Higher Returns MORN or NDAQ?

    Nasdaq has a net margin of 21.02% compared to Morningstar's net margin of 16.09%. Morningstar's return on equity of 23.47% beat Nasdaq's return on equity of 9.57%.

    Company Gross Margin Earnings Per Share Invested Capital
    MORN
    Morningstar
    60.89% $2.77 $2.4B
    NDAQ
    Nasdaq
    38.59% $0.53 $20.9B
  • What do Analysts Say About MORN or NDAQ?

    Morningstar has a consensus price target of --, signalling upside risk potential of 10.18%. On the other hand Nasdaq has an analysts' consensus of $84.17 which suggests that it could grow by 8.32%. Given that Morningstar has higher upside potential than Nasdaq, analysts believe Morningstar is more attractive than Nasdaq.

    Company Buy Ratings Hold Ratings Sell Ratings
    MORN
    Morningstar
    0 0 0
    NDAQ
    Nasdaq
    4 7 0
  • Is MORN or NDAQ More Risky?

    Morningstar has a beta of 1.193, which suggesting that the stock is 19.256% more volatile than S&P 500. In comparison Nasdaq has a beta of 0.968, suggesting its less volatile than the S&P 500 by 3.25%.

  • Which is a Better Dividend Stock MORN or NDAQ?

    Morningstar has a quarterly dividend of $0.41 per share corresponding to a yield of 0.48%. Nasdaq offers a yield of 1.21% to investors and pays a quarterly dividend of $0.24 per share. Morningstar pays 45.29% of its earnings as a dividend. Nasdaq pays out 41.64% of its earnings as a dividend. Both of these payout ratios are sufficient to cover dividend payouts with earnings for the foreseeable future.

  • Which has Better Financial Ratios MORN or NDAQ?

    Morningstar quarterly revenues are $569.4M, which are smaller than Nasdaq quarterly revenues of $1.9B. Morningstar's net income of $119.7M is lower than Nasdaq's net income of $306M. Notably, Morningstar's price-to-earnings ratio is 44.96x while Nasdaq's PE ratio is 46.53x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Morningstar is 6.60x versus 6.34x for Nasdaq. Usually stocks with elevated PS ratios are considered overvalued.

    Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income
    MORN
    Morningstar
    6.60x 44.96x $569.4M $119.7M
    NDAQ
    Nasdaq
    6.34x 46.53x $1.9B $306M
  • Which has Higher Returns MORN or VALU?

    Value Line has a net margin of 21.02% compared to Morningstar's net margin of 64.3%. Morningstar's return on equity of 23.47% beat Value Line's return on equity of 24.37%.

    Company Gross Margin Earnings Per Share Invested Capital
    MORN
    Morningstar
    60.89% $2.77 $2.4B
    VALU
    Value Line
    59.56% $0.60 $96.7M
  • What do Analysts Say About MORN or VALU?

    Morningstar has a consensus price target of --, signalling upside risk potential of 10.18%. On the other hand Value Line has an analysts' consensus of -- which suggests that it could fall by --. Given that Morningstar has higher upside potential than Value Line, analysts believe Morningstar is more attractive than Value Line.

    Company Buy Ratings Hold Ratings Sell Ratings
    MORN
    Morningstar
    0 0 0
    VALU
    Value Line
    0 0 0
  • Is MORN or VALU More Risky?

    Morningstar has a beta of 1.193, which suggesting that the stock is 19.256% more volatile than S&P 500. In comparison Value Line has a beta of 0.807, suggesting its less volatile than the S&P 500 by 19.301%.

  • Which is a Better Dividend Stock MORN or VALU?

    Morningstar has a quarterly dividend of $0.41 per share corresponding to a yield of 0.48%. Value Line offers a yield of 2.18% to investors and pays a quarterly dividend of $0.30 per share. Morningstar pays 45.29% of its earnings as a dividend. Value Line pays out 55.54% of its earnings as a dividend. Both of these payout ratios are sufficient to cover dividend payouts with earnings for the foreseeable future.

  • Which has Better Financial Ratios MORN or VALU?

    Morningstar quarterly revenues are $569.4M, which are larger than Value Line quarterly revenues of $8.8M. Morningstar's net income of $119.7M is higher than Value Line's net income of $5.7M. Notably, Morningstar's price-to-earnings ratio is 44.96x while Value Line's PE ratio is 23.04x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Morningstar is 6.60x versus 14.23x for Value Line. Usually stocks with elevated PS ratios are considered overvalued.

    Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income
    MORN
    Morningstar
    6.60x 44.96x $569.4M $119.7M
    VALU
    Value Line
    14.23x 23.04x $8.8M $5.7M

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Popular

Why Caesars’ Digital Arm May Be the Gaming Giant’s Best-Kept Secret
Why Caesars’ Digital Arm May Be the Gaming Giant’s Best-Kept Secret

It’s not often that a company with the scale and…

Will Tyson Foods Stock Bounce Back?
Will Tyson Foods Stock Bounce Back?

Tyson Foods, Inc. (NYSE:TSN) is one of the biggest food…

Will Iovance Biotherapeutics Stock Bounce Back?
Will Iovance Biotherapeutics Stock Bounce Back?

Iovance Biotherapeutics (NASDAQ:IOVA) is a fledgling pharmaceutical company that specializes…

Stock Ideas

Buy
64
Is AAPL Stock a Buy?

Market Cap: $3.8T
P/E Ratio: 42x

Buy
52
Is NVDA Stock a Buy?

Market Cap: $3.3T
P/E Ratio: 113x

Buy
55
Is MSFT Stock a Buy?

Market Cap: $3.2T
P/E Ratio: 37x

Alerts

Buy
61
QMCO alert for Dec 21

Quantum [QMCO] is up 26.28% over the past day.

Sell
46
NUKK alert for Dec 21

Nukkleus [NUKK] is down 22.94% over the past day.

Sell
1
IIPR alert for Dec 21

Innovative Industrial Properties [IIPR] is down 22.7% over the past day.

THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS

Show me the best stock